Silence Therapeutics plc Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Silence Therapeutics plc (SLNCF) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -2.20% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-03-05
- Silence Therapeutics plc effective income tax rate reconciliation, tax credit, percent for fiscal 2025 was -2.20%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month |
|---|---|
| 2025-12-31 | -2.20% 10-K · filed 2026-03-05 |